trending Market Intelligence /marketintelligence/en/news-insights/trending/vtEYtVw7iEGfbJS2BA5KWw2 content esgSubNav
In This List

Virbac postpones option to buy remaining stake in Centrovet

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Virbac postpones option to buy remaining stake in Centrovet

Virbac SA said it will defer the option to buy the remaining 49% stake in animal health and aquaculture company Centrovet Laboratories Inc. for three years.

The French company has held a 51% stake in Santiago, Chile-based Centrovet since November 2012.

Virbac said exercising the option in late 2017 would have added to the company's debt burden at a time when it is seeking to deleverage.